IOVA240531C00006500 Option on Iovance Biotherapeutics
| IOVA Stock | USD 8.16 0.27 3.20% |
Iovance Biotherapeutics' latest option contracts expiring on 2024-06-21 are carrying combined implied volatility of 87.63 with a put-to-call open interest ratio of 0.26 over 82 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-06-21. The current put volume is at 68.0, with calls trading at the volume of 71.0. This yields a 0.96 put-to-call volume ratio.
Open Interest Against 2024-06-21 Option Contracts
2024-06-21
The chart above shows Iovance Biotherapeutics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Iovance Biotherapeutics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Iovance Biotherapeutics' option, there is no secondary market available for investors to trade.
Iovance Biotherapeutics Maximum Pain Price across 2024-06-21 Option Contracts
Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Iovance Biotherapeutics close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Iovance Biotherapeutics' option chain provides insight into all available option contracts written on Iovance Biotherapeutics' stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Iovance Biotherapeutics' stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Iovance option contract.
In The Money vs. Out of Money Option Contracts on Iovance Biotherapeutics
Analyzing Iovance Biotherapeutics' in-the-money options over time can help investors to take a profitable long position in Iovance Biotherapeutics regardless of its overall volatility. This is especially true when Iovance Biotherapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Iovance Biotherapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Iovance Biotherapeutics' stock while costing only a fraction of its price.
Iovance Biotherapeutics' stock options are financial instruments that give investors the right to buy or sell shares of Iovance Biotherapeutics common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Iovance stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Iovance Biotherapeutics' stock price goes up or down, the stock options follow.
At present, Iovance Biotherapeutics' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 246.9 M, whereas Common Stock Total Equity is forecasted to decline to 4,118. Iovance Biotherapeutics In The Money Call Balance
When Iovance Biotherapeutics' strike price is surpassing the current stock price, the option contract against Iovance Biotherapeutics stock is said to be in the money. When it comes to buying Iovance Biotherapeutics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Iovance Biotherapeutics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Iovance Current Options Market Mood
Iovance Biotherapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Iovance Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of Iovance Biotherapeutics' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Iovance Biotherapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Iovance Biotherapeutics' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current Iovance contract
Base on the Rule 16, the options market is currently suggesting that Iovance Biotherapeutics will have an average daily up or down price movement of about 5.48% per day over the life of the 2024-06-21 option contract. With Iovance Biotherapeutics trading at USD 8.16, that is roughly USD 0.45. If you think that the market is fully incorporating Iovance Biotherapeutics' daily price movement you should consider buying Iovance Biotherapeutics options at the current volatility level of 87.63%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Iovance |
Purchasing Iovance Biotherapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Iovance calls. Remember, the seller must deliver Iovance Biotherapeutics stock to the call owner when a call is exercised.
Iovance Biotherapeutics Option Chain
When Iovance Biotherapeutics' strike price is surpassing the current stock price, the option contract against Iovance Biotherapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
2024-06-212024-06-282024-07-052024-07-122024-07-192024-07-262024-08-022024-09-202024-12-202025-01-172026-01-16
Iovance Biotherapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Iovance. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Iovance. It also shows strike prices and maturity days for a Iovance Biotherapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-06-21 CALL at $1.0 | 0.9868 | 0.003 | 30 | 2024-06-21 | 5.0 - 9.5 | 10.0 | In |
Call | 2024-06-21 CALL at $2.5 | 0.9542 | 0.0118 | 64 | 2024-06-21 | 5.1 - 6.7 | 9.76 | In |
Call | 2024-06-21 CALL at $3.0 | 0.9583 | 0.0149 | 0 | 2024-06-21 | 4.6 - 6.0 | 0.0 | In |
Call | 2024-06-21 CALL at $3.5 | 0.9511 | 0.0196 | 0 | 2024-06-21 | 4.1 - 5.5 | 0.0 | In |
Call | 2024-06-21 CALL at $4.0 | 0.8958 | 0.0256 | 259 | 2024-06-21 | 3.6 - 4.7 | 7.3 | In |
Call | 2024-06-21 CALL at $4.5 | 0.9709 | 0.0235 | 0 | 2024-06-21 | 3.4 - 4.0 | 0.0 | In |
Call | 2024-06-21 CALL at $5.0 | 0.966 | 0.0316 | 672 | 2024-06-21 | 2.8 - 3.6 | 3.43 | In |
Call | 2024-06-21 CALL at $5.5 | 0.9433 | 0.0511 | 0 | 2024-06-21 | 2.25 - 3.2 | 0.0 | In |
Call | 2024-06-21 CALL at $6.0 | 0.9518 | 0.0622 | 428 | 2024-06-21 | 1.8 - 2.6 | 2.0 | In |
Call | 2024-06-21 CALL at $6.5 | 0.9164 | 0.1066 | 0 | 2024-06-21 | 1.3 - 2.15 | 0.0 | In |
Call | 2024-06-21 CALL at $7.0 | 0.7921 | 0.1603 | 14 | 2024-06-21 | 0.85 - 1.4 | 1.1 | In |
Call | 2024-06-21 CALL at $7.5 | 0.7782 | 0.3019 | 2946 | 2024-06-21 | 0.7 - 1.2 | 0.8 | In |
Call | 2024-06-21 CALL at $8.0 | 0.6039 | 0.4917 | 299 | 2024-06-21 | 0.35 - 0.5 | 0.4 | In |
Call | 2024-06-21 CALL at $8.5 | 0.337 | 0.5195 | 142 | 2024-06-21 | 0.15 - 0.25 | 0.15 | Out |
Call | 2024-06-21 CALL at $9.0 | 0.2064 | 0.3148 | 2022 | 2024-06-21 | 0.0 - 0.15 | 0.1 | Out |
Call | 2024-06-21 CALL at $9.5 | 0.1371 | 0.2061 | 792 | 2024-06-21 | 0.0 - 0.1 | 0.07 | Out |
Call | 2024-06-21 CALL at $10.0 | 0.0948 | 0.1414 | 4813 | 2024-06-21 | 0.0 - 0.05 | 0.05 | Out |
Call | 2024-06-21 CALL at $11.5 | 0.0362 | 0.0536 | 59 | 2024-06-21 | 0.0 - 0.75 | 0.02 | Out |
Call | 2024-06-21 CALL at $16.0 | 0.0465 | 0.033 | 6944 | 2024-06-21 | 0.0 - 0.05 | 0.05 | Out |
Put | 2024-06-21 PUT at $7.5 | -0.1408 | 0.3332 | 1016 | 2024-06-21 | 0.05 - 0.1 | 0.05 | Out |
Put | 2024-06-21 PUT at $8.0 | -0.3886 | 0.5506 | 1455 | 2024-06-21 | 0.2 - 0.75 | 0.2 | Out |
Put | 2024-06-21 PUT at $8.5 | -0.6298 | 0.4426 | 511 | 2024-06-21 | 0.35 - 0.8 | 0.54 | In |
Put | 2024-06-21 PUT at $9.0 | -0.8355 | 0.32 | 3220 | 2024-06-21 | 0.75 - 1.15 | 0.9 | In |
Put | 2024-06-21 PUT at $9.5 | -0.8184 | 0.2109 | 1662 | 2024-06-21 | 1.3 - 1.6 | 1.2 | In |
Put | 2024-06-21 PUT at $10.0 | -0.7777 | 0.1586 | 3949 | 2024-06-21 | 1.45 - 2.05 | 1.77 | In |
Put | 2024-06-21 PUT at $10.5 | -0.7327 | 0.1291 | 106 | 2024-06-21 | 1.95 - 2.7 | 1.6 | In |
Put | 2024-06-21 PUT at $11.0 | -0.7876 | 0.114 | 1055 | 2024-06-21 | 2.4 - 3.1 | 2.75 | In |
Put | 2024-06-21 PUT at $11.5 | -0.8478 | 0.099 | 0 | 2024-06-21 | 3.1 - 3.5 | 0.0 | In |
Put | 2024-06-21 PUT at $12.0 | -0.9217 | 0.072 | 0 | 2024-06-21 | 3.5 - 4.3 | 0.0 | In |
Put | 2024-06-21 PUT at $12.5 | -0.9766 | 0.0335 | 220 | 2024-06-21 | 4.1 - 4.6 | 4.72 | In |
Put | 2024-06-21 PUT at $13.0 | -0.9779 | 0.0296 | 0 | 2024-06-21 | 4.4 - 5.3 | 0.0 | In |
Put | 2024-06-21 PUT at $13.5 | -0.9325 | 0.0526 | 0 | 2024-06-21 | 5.0 - 5.8 | 0.0 | In |
Put | 2024-06-21 PUT at $14.0 | -0.8342 | 0.0678 | 224 | 2024-06-21 | 5.5 - 6.1 | 5.8 | In |
Put | 2024-06-21 PUT at $14.5 | -0.9064 | 0.054 | 0 | 2024-06-21 | 6.0 - 6.9 | 0.0 | In |
Put | 2024-06-21 PUT at $15.0 | -0.8077 | 0.0627 | 101 | 2024-06-21 | 6.4 - 7.2 | 6.5 | In |
Put | 2024-06-21 PUT at $15.5 | -0.7421 | 0.0604 | 0 | 2024-06-21 | 6.9 - 9.0 | 0.0 | In |
Put | 2024-06-21 PUT at $16.0 | -0.849 | 0.0552 | 21 | 2024-06-21 | 7.4 - 8.1 | 6.85 | In |
Put | 2024-06-21 PUT at $17.0 | -0.8732 | 0.0488 | 0 | 2024-06-21 | 8.4 - 9.7 | 0.0 | In |
Put | 2024-06-21 PUT at $17.5 | -0.8958 | 0.044 | 12 | 2024-06-21 | 9.0 - 9.5 | 8.8 | In |
Put | 2024-06-21 PUT at $18.0 | -0.947 | 0.0309 | 0 | 2024-06-21 | 9.4 - 10.4 | 0.0 | In |
Put | 2024-06-21 PUT at $19.0 | -0.816 | 0.0479 | 1 | 2024-06-21 | 10.5 - 12.0 | 10.1 | In |
Put | 2024-06-21 PUT at $20.0 | -0.9848 | 0.0124 | 6 | 2024-06-21 | 11.4 - 12.3 | 7.6 | In |
Put | 2024-06-21 PUT at $21.0 | -0.7183 | 0.0453 | 0 | 2024-06-21 | 12.4 - 15.0 | 0.0 | In |
Put | 2024-06-21 PUT at $22.0 | -0.813 | 0.0425 | 0 | 2024-06-21 | 12.4 - 14.3 | 0.0 | In |
Put | 2024-06-21 PUT at $23.0 | -0.8433 | 0.0393 | 0 | 2024-06-21 | 14.6 - 15.8 | 9.5 | In |
Put | 2024-06-21 PUT at $24.0 | -0.9861 | 0.0098 | 0 | 2024-06-21 | 15.4 - 16.3 | 0.0 | In |
Put | 2024-06-21 PUT at $25.0 | -0.9863 | 0.0094 | 0 | 2024-06-21 | 16.4 - 17.3 | 13.85 | In |
Put | 2024-06-21 PUT at $26.0 | -0.8795 | 0.0329 | 0 | 2024-06-21 | 17.4 - 18.8 | 0.0 | In |
Put | 2024-06-21 PUT at $30.0 | -0.9874 | 0.0077 | 0 | 2024-06-21 | 21.4 - 22.3 | 0.0 | In |
Iovance Total Stockholder Equity
Total Stockholder Equity |
|
Iovance Biotherapeutics Corporate Management
| Esq JD | President, CEO | Profile | |
| Igor Bilinsky | Chief Officer | Profile | |
| Friedrich MD | Chief Officer | Profile | |
| Howard MBA | Chief Officer | Profile | |
| JeanMarc MBA | Chief Officer | Profile | |
| Sara Pellegrino | Vice Relations | Profile | |
| Madan Jagasia | Ex Affairs | Profile |
Additional Information and Resources on Investing in Iovance Stock
When determining whether Iovance Biotherapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Iovance Biotherapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Iovance Biotherapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Iovance Biotherapeutics Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Iovance Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade Iovance Stock refer to our How to Trade Iovance Stock guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Iovance Biotherapeutics. If investors know Iovance will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Iovance Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.81) | Revenue Per Share 0.008 | Return On Assets (0.34) | Return On Equity (0.67) |
The market value of Iovance Biotherapeutics is measured differently than its book value, which is the value of Iovance that is recorded on the company's balance sheet. Investors also form their own opinion of Iovance Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Iovance Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Iovance Biotherapeutics' market value can be influenced by many factors that don't directly affect Iovance Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Iovance Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Iovance Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Iovance Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.